{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:52:21Z","timestamp":1786121541960,"version":"build-2736575974"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>As part of a programme developing human-relevant new approach methodologies (NAMs) for next-generation risk assessment (NGRA), we utilised a human air-liquid interface (ALI) bronchial epithelial model (MucilAir\u2122) to assess epithelial responses to nebulised protease exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Protease doses of 0.005, 0.08, 2, and 24 \u00b5g\/cm\n                      <jats:sup>2<\/jats:sup>\n                      were applied to MucilAir\u2122 inserts via nebulisation using a Vitrocell\n                      <jats:sup>\u00ae<\/jats:sup>\n                      Cloud Alpha. Effects on epithelial barrier integrity, cytokine release, extracellular vesicle (EV) profiles, and EV transcriptomic cargo were evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Phosphate-buffered saline (PBS) nebulisation produced no detectable barrier effects using the methods described. Protease doses of 2 \u00b5g\/cm\n                      <jats:sup>2<\/jats:sup>\n                      or lower caused no significant responses compared with PBS controls. Protease doses of 24 \u00b5g\/cm\n                      <jats:sup>2<\/jats:sup>\n                      induced reductions in TEER, GRO-\u03b1, IL-8\/CXCL8, IL-9, and VEGF production, but increased MIF production, and EV alterations, indicating barrier disruption. Transcriptomic analysis of MucilAir\u2122-derived EVs indicates a protease dose-dependent increase in differentially expressed microRNAs (miRNAs) that were enriched for pathways involved in epithelial signalling, immune and inflammatory regulation, cytoskeletal organisation, and cell survival and repair.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      These findings demonstrate the suitability of nebulised dosing for assessing airborne protease effects in bronchial ALI cultures. These data also highlight EV-miRNA profiling as a powerful, non-invasive readout that captures early molecular perturbations not detectable by conventional functional assays alone. Through identification of TEER, EV, and cytokine disruption thresholds to protease through statistical modelling, this work strengthens the methodological basis for generating NAM-aligned\n                      <jats:italic>in vitro<\/jats:italic>\n                      data to support risk assessment of inhaled enzymes and other airborne materials.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1875147","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T05:27:39Z","timestamp":1786080459000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Human bronchial air-liquid interface responses to nebulised protease exposure"],"prefix":"10.3389","volume":"17","author":[{"given":"Georgina","family":"Hopkins","sequence":"first","affiliation":[{"name":"School of Life Sciences, The University of Nottingham","place":["Nottingham, United Kingdom"]},{"name":"School of Medicine, Pharmacy, and Biosciences, Aston University","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sheffield","sequence":"additional","affiliation":[{"name":"Safety, Environmental and Regulatory Science, Unilever","place":["Sharnbrook, Bedfordshire, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Barlow","sequence":"additional","affiliation":[{"name":"Safety, Environmental and Regulatory Science, Unilever","place":["Sharnbrook, Bedfordshire, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Lalljie","sequence":"additional","affiliation":[{"name":"Safety, Environmental and Regulatory Science, Unilever","place":["Sharnbrook, Bedfordshire, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"James","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Science, The University of Nottingham","place":["Nottingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Cochrane","sequence":"additional","affiliation":[{"name":"Safety, Environmental and Regulatory Science, Unilever","place":["Sharnbrook, Bedfordshire, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy C.","family":"Fairclough","sequence":"additional","affiliation":[{"name":"School of Life Sciences, The University of Nottingham","place":["Nottingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2024.1335110","article-title":"Impact of a varied set of stimuli on a suite of immunological parameters within peripheral blood mononuclear cells: toward a non-animal approach for assessing immune modulation by materials intended for human use","volume":"6","author":"Cochrane","year":"2024","journal-title":"Front Toxicol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2025.1426132","article-title":"Evaluation of a non-animal toolbox informed by adverse outcome pathways for human inhalation safety","volume":"7","author":"de \u00c1vila","year":"2025","journal-title":"Front Toxicol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.comtox.2018.06.001","article-title":"Principles underpinning the use of new methodologies in the risk assessment of cosmetic ingredients","volume":"7","author":"Dent","year":"2018","journal-title":"Comput Toxicol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2021.105026","article-title":"Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients","volume":"125","author":"Dent","year":"2021","journal-title":"Regul Toxicol Pharm"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.3390\/ijerph18073332","article-title":"Investigating molecular mechanisms of immunotoxicity and the utility of ToxCast for immunotoxicity screening of chemicals added to food","volume":"18","author":"Naidenko","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/ijerph20010273","article-title":"Immunotoxicity in vitro assays for environmental pollutants under paradigm shift in toxicity tests","volume":"20","author":"Wang","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/occmed\/kqr107","article-title":"Occupational asthma and rhinitis due to detergent enzymes in healthcare","volume":"61","author":"Adisesh","year":"2011","journal-title":"Occup Med (Lond)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2009.12.014","article-title":"Defining occupational and consumer exposure limits for enzyme protein respiratory allergens under REACH","volume":"268","author":"Basketter","year":"2010","journal-title":"Toxicology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(69)92165-5","article-title":"Pulmonary disease due to inhalation of derivatives of Bacillus subtilis containing proteolytic enzyme","volume":"1","author":"Flindt","year":"1969","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s1081-1206(10)61646-8","article-title":"Control of occupational asthma and allergy in the detergent industry","volume":"90","author":"Sarlo","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2026.1781231","article-title":"Impact of liquid dosing and associated cell \u2018drowning\u2019 in a 3D human bronchial epithelial model used for protease exposure studies","volume":"8","author":"Hopkins","year":"2026","journal-title":"Front Toxicol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.tox.2007.11.001","article-title":"An in vitro approach to assess the toxicity of inhaled tobacco smoke components: Nicotine, cadmium, formaldehyde and urethane","volume":"244","author":"Balharry","year":"2008","journal-title":"Toxicology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2021.105022","article-title":"Evaluation of the toxicity of sodium dodecyl sulphate (SDS) in the MucilAir\u2122 human airway model in vitro","volume":"125","author":"Welch","year":"2021","journal-title":"Regul Toxicol Pharm"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2023.1264331","article-title":"Liquid application dosing alters the physiology of air-liquid interface (ALI) primary human bronchial epithelial cell\/lung fibroblast co-cultures and in vitro testing relevant endpoints","volume":"5","author":"Mallek","year":"2024","journal-title":"Front Toxicol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1025348","article-title":"Liquid biopsy\u201d - extracellular vesicles as potential novel players towards precision medicine in asthma","volume":"13","author":"Ambro\u017cej","year":"2022","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12931-020-01402-3","article-title":"T2 and T17 cytokines alter the cargo and function of airway epithelium-derived extracellular vesicles","volume":"21","author":"Ax","year":"2020","journal-title":"Respir Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.3390\/ijms26125791","article-title":"The role of epithelial-derived extracellular vesicles in allergic sensitisation: a systematic review","volume":"26","author":"Browne","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.3390\/ijms25084492","article-title":"The role of extracellular vesicles in allergic sensitization: a systematic review","volume":"25","author":"Tucis","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cotox.2018.03.004","article-title":"The adverse outcome pathway: a multifaceted framework supporting 21(st) century toxicology","volume":"9","author":"Ankley","year":"2018","journal-title":"Curr Opin Toxicol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12931-020-01423-y","article-title":"Extracellular vesicles: novel communicators in lung diseases","volume":"21","author":"Mohan","year":"2020","journal-title":"Respir Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2023-221302","article-title":"Environmental pollutants exposure-derived extracellular vesicles: crucial players in respiratory disorders","volume":"79","author":"Shen","year":"2024","journal-title":"Thorax"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/all.14008","article-title":"Human airway epithelial extracellular vesicle miRNA signature is altered upon asthma development","volume":"75","author":"Bartel","year":"2020","journal-title":"Allergy"},{"key":"B23","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.celrep.2019.01.002","article-title":"Increased hematopoietic extracellular RNAs and vesicles in the lung during allergic airway responses","volume":"26","author":"Pua","year":"2019","journal-title":"Cell Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.12688\/f1000research.94159.2","article-title":"miND (miRNA NGS Discovery pipeline): a small RNA-seq analysis pipeline and report generator for microRNA biomarker discovery studies [version 1; peer review: 2 approved with reservations","volume":"11","author":"Diendorfer","year":"2022","journal-title":"F1000Research"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2013-0479oc","article-title":"Efficient bioactive delivery of aerosolized drugs to human pulmonary epithelial cells cultured in air-liquid interface conditions","volume":"51","author":"Lenz","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2020.104870","article-title":"Comparison of experimentally measured and computational fluid dynamic predicted deposition and deposition uniformity of monodisperse solid particles in the Vitrocell\u00ae AMES 48 air-liquid-interface in-vitro exposure system","volume":"67","author":"Oldham","year":"2020","journal-title":"Toxicol Vitro"},{"key":"B28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/02786826.2019.1676877","article-title":"Deposition efficiency and uniformity of monodisperse solid particle deposition in the Vitrocell\u00ae 24\/48 air\u2013liquid-interface in vitro exposure system","volume":"54","author":"Oldham","year":"2020","journal-title":"Aerosol Sci Technol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2017.04.021","article-title":"Characterization of the Vitrocell\u00ae 24\/48 aerosol exposure system for its use in exposures to liquid aerosols","volume":"42","author":"Steiner","year":"2017","journal-title":"Toxicol Vitro"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.3390\/ma16051975","article-title":"Impact of natural-based viscosity modifiers of inhalation drugs on the dynamic surface properties of the pulmonary surfactant","volume":"16","author":"Dobrowolska","year":"2023","journal-title":"Materials (Basel)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16010097","article-title":"Towards more precise targeting of inhaled aerosols to different areas of the respiratory system","volume":"16","author":"Sosnowski","year":"2024","journal-title":"Pharmaceutics"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.impact.2022.100439","article-title":"An inter-laboratory effort to harmonize the cell-delivered in vitro dose of aerosolized materials","volume":"28","author":"Bannuscher","year":"2022","journal-title":"NanoImpact"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/02786820119122","article-title":"Particle deposition in a multiple-path model of the human lung","volume":"34","author":"Asgharian","year":"2001","journal-title":"Aerosol Sci Technol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2024.1431790","article-title":"New approach methodologies (NAMs) for the in vitro assessment of cleaning products for respiratory irritation: workshop report","volume":"6","author":"Haber","year":"2024","journal-title":"Front Toxicol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1039\/d5en00299k","article-title":"LungDepo: modelling the regional particle deposition in the human lung via the Enalos Cloud platform","volume":"12","author":"Mintis","year":"2025","journal-title":"Environ Sci Nano"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.3390\/ijms20133222","article-title":"IL-13 impairs tight junctions in airway epithelia","volume":"20","author":"Schmidt","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2011.183.1_meetingabstracts.a2042","article-title":"Serine proteases degrade airway mucins in cystic fibrosis","volume":"79","author":"Henke","year":"2011","journal-title":"Infect Immun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22095018","article-title":"Proteases, mucus, and mucosal immunity in chronic lung disease","volume":"22","author":"McKelvey","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/bf03257159","article-title":"The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapy","volume":"1","author":"Pease","year":"2002","journal-title":"Am J Respir Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/cc5042","article-title":"The early responses of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival","volume":"10","author":"Mura","year":"2006","journal-title":"Crit Care"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1271\/bbb.64.1764","article-title":"Native and acid-denatured L-lactate dehydrogenase are different in the lysosomal proteinases involving in their overall degradation","volume":"64","author":"Ohshita","year":"2000","journal-title":"Biosci Biotechnol Biochem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10030622","article-title":"Side-directed release of differential extracellular vesicle-associated microRNA profiles from bronchial epithelial cells of healthy and asthmatic subjects","volume":"10","author":"Schindler","year":"2022","journal-title":"Biomedicines"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1289\/isee.2013.p-3-16-22","article-title":"Managing the risk of occupational allergy in the enzyme detergent industry","volume":"12","author":"Basketter","year":"2015","journal-title":"J Occup Environ Hyg"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1875147\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T05:27:40Z","timestamp":1786080460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1875147\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2026.1875147"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1875147","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"article-number":"1875147"}}